Correlation Engine 2.0
Clear Search sequence regions


  • cellular processes (1)
  • children (1)
  • diagnosis (4)
  • humans (1)
  • mirnas (3)
  • mirnas (3)
  • patients (1)
  • prognosis (3)
  • retinoblastoma (9)
  • rna (1)
  • Sizes of these terms reflect their relevance to your search.

    Retinoblastoma (RB) is a prevalent primitive intraocular malignancy in children, particularly in those younger than age 3 years. RB is caused by mutations in the RB1 gene. In developing countries, mortality rates for this type of cancer are still high, whereas industrialized countries have achieved a survival rate of >95%-98%. Untreated, the condition can be fatal, underscoring the importance of early diagnosis. The existing treatments primarily consist of surgery, radiotherapy, and chemotherapy. The detrimental effects of radiation and chemotherapeutic drugs have been documented as factors that contribute to increased mortality rates and negatively affect the quality of life for patients. MicroRNA (miRNA), a type of noncoding RNA, exerts a substantial influence on RB development and the emergence of treatment resistance by regulating diverse cellular processes. This review highlights recent developments in the involvement of miRNAs in RB. This encompasses the clinical significance of miRNAs in the diagnosis, prognosis, and treatment of RB. Additionally, this paper examines the regulatory mechanisms of miRNAs in RB and explores potential therapeutic interventions. This paper provides an overview of the current and emerging treatment options for RB, focusing on recent studies investigating the application of different types of nanoparticles for the diagnosis and treatment of this condition. Copyright © 2024 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

    Citation

    Shivam Rajput, Rishabha Malviya, Prerna Uniyal. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2024 Oct;59(5):281-299

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 38369298

    View Full Text